Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar

NCT03662022 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

144000

Enrollment

OTHER

Sponsor class

Conditions

Leprosy

Interventions

DRUG: Rifampicin

Sponsor

Institute of Tropical Medicine, Belgium

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]